Growth Potential ConcernsAlthough I would like to get excited about the growth trajectory for Leviathan, I'm having a tough time finding a reason to think that this company is in any better position than others who are already in the process of executing a 'roll-up' strategy. While the Pulse Rx acquisition does give the company an interesting angle of developing cash-flowing assets (pharmacies) before transitioning into - effectively - dispensaries, these locations will still be required to go through the same license-application process like all other companies -- so I can't see this being a huge advantage.
In terms of cultivation, I can't find any reason to think that this will be the driving force behind Leviathan's success given that the facility is only in the process of being constructed. Are people betting on pipeline acquisitions here or am I missing something?